Literature DB >> 24089247

Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity.

Eric T Alexander1, Michael C Phillips.   

Abstract

It is important to understand HDL heterogeneity because various subspecies possess different functionalities. To understand the origins of HDL heterogeneity arising from the existence of particles containing only apoA-I (LpA-I) and particles containing both apoA-I and apoA-II (LpA-I+A-II), we compared the abilities of both proteins to promote ABCA1-mediated efflux of cholesterol from HepG2 cells and form nascent HDL particles. When added separately, exogenous apoA-I and apoA-II were equally effective in promoting cholesterol efflux, although the resultant LpA-I and LpA-II particles had different sizes. When apoA-I and apoA-II were mixed together at initial molar ratios ranging from 1:1 to 16:1 to generate nascent LpA-I+A-II HDL particles, the particle size distribution altered, and the two proteins were incorporated into the nascent HDL in proportion to their initial ratio. Both proteins formed nascent HDL particles with equal efficiency, and the relative amounts of apoA-I and apoA-II incorporation were driven by mass action. The ratio of lipid-free apoA-I and apoA-II available at the surface of ABCA1-expressing cells is a major factor in determining the contents of these proteins in nascent HDL. Manipulation of this ratio provides a means of altering the relative distribution of LpA-I and LpA-I+A-II HDL particles.

Entities:  

Keywords:  ATP binding cassette A1; cholesterol; lipoprotein; phospholipid

Mesh:

Substances:

Year:  2013        PMID: 24089247      PMCID: PMC3826692          DOI: 10.1194/jlr.M043109

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  55 in total

1.  Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

Authors:  Baiba K Gillard; Hu-Yu Alice Lin; John B Massey; Henry J Pownall
Journal:  Biochim Biophys Acta       Date:  2009-07-25

Review 2.  Biological activities of HDL subpopulations and their relevance to cardiovascular disease.

Authors:  Laurent Camont; M John Chapman; Anatol Kontush
Journal:  Trends Mol Med       Date:  2011-08-10       Impact factor: 11.951

Review 3.  High-density lipoprotein heterogeneity and function in reverse cholesterol transport.

Authors:  George H Rothblat; Michael C Phillips
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

Review 4.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

5.  Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2012-06-01       Impact factor: 3.162

6.  Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.

Authors:  Corina Rosales; Baiba K Gillard; Harry S Courtney; Francisco Blanco-Vaca; Henry J Pownall
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

7.  The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.

Authors:  Daniel J Rader; Eric T Alexander; Ginny L Weibel; Jeffrey Billheimer; George H Rothblat
Journal:  J Lipid Res       Date:  2008-12-08       Impact factor: 5.922

8.  Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles.

Authors:  Charulatha Vedhachalam; Phu T Duong; Margaret Nickel; David Nguyen; Padmaja Dhanasekaran; Hiroyuki Saito; George H Rothblat; Sissel Lund-Katz; Michael C Phillips
Journal:  J Biol Chem       Date:  2007-06-29       Impact factor: 5.157

9.  Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.

Authors:  Rong Huang; R A Gangani D Silva; W Gray Jerome; Anatol Kontush; M John Chapman; Linda K Curtiss; Timothy J Hodges; W Sean Davidson
Journal:  Nat Struct Mol Biol       Date:  2011-03-13       Impact factor: 15.369

10.  Comparison of apoA-I helical structure and stability in discoidal and spherical HDL particles by HX and mass spectrometry.

Authors:  Palaniappan Sevugan Chetty; David Nguyen; Margaret Nickel; Sissel Lund-Katz; Leland Mayne; S Walter Englander; Michael C Phillips
Journal:  J Lipid Res       Date:  2013-04-10       Impact factor: 5.922

View more
  2 in total

1.  Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1.

Authors:  John T Melchior; Scott E Street; Allison B Andraski; Jeremy D Furtado; Frank M Sacks; Rebecca L Shute; Emily I Greve; Debi K Swertfeger; Hailong Li; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Lipid Res       Date:  2017-05-05       Impact factor: 5.922

2.  Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men.

Authors:  Olga Gursky
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.